Please login to the form below

Not currently logged in
Email:
Password:

EMD Serono appoints new US chief medical officer

Joseph Leveque to enhance firm’s clinical presence in the US
EMD Serono Joseph Leveque

EMD Serono has appointed Joseph Leveque as chief medical officer in the US.

Dr Leveque will be responsible for working with the regulatory, medical and development teams to enhance EMD Serono's clinical presence in the US and to drive the execution of key medical initiatives. 

Leveque brings over 20 years of experience in areas of strategic leadership, advancing medical and clinical programs, as well as life cycle management. 

Paris Panayiotopoulos, president and managing director of EMD Serono, said: “Dr. Leveque's substantial experience in managing integrated global medical affairs teams will be significant to furthering our specialty care focus in neurology, oncology, fertility, and endocrinology and bringing our pipeline forward.”

Leveque formerly served at Bristol-Myers Squibb, where he was the head of US Medical for Oncology. During his time there, he was responsible for providing strategic leadership and management for marketed and near-term pipeline oncology assets. 

1st October 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics